Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 589,013 |
|
|||||
| News | - | ||||||
| Day High | 20.80 | Low High |
|||||
| Day Low | 20.13 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Syndax Pharmaceuticals Inc | SNDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.22 | -1.06% | 20.57 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 20.43 | 20.13 | 20.80 | 20.57 | 20.79 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,062 | 589,013 | $ 20.54 | $ 12,095,898 | - | 11.215 - 25.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:12:12 | 50 | $ 20.80 | USD |
Syndax Pharmaceuticals (SNDX) Options Flow Summary
Syndax Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.75B | 84.97M | - | 0 | -209.36M | -2.46 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Syndax Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNDX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.74 | 21.54 | 20.13 | 20.77 | 814,158 | -0.17 | -0.82% |
| 1 Month | 23.18 | 24.375 | 20.13 | 22.11 | 914,142 | -2.61 | -11.26% |
| 3 Months | 20.59 | 25.34 | 20.085 | 22.66 | 1,101,382 | -0.02 | -0.10% |
| 6 Months | 12.24 | 25.34 | 11.51 | 19.81 | 1,360,194 | 8.33 | 68.06% |
| 1 Year | 21.13 | 25.34 | 11.215 | 18.51 | 1,291,534 | -0.56 | -2.65% |
| 3 Years | 15.32 | 29.86 | 11.215 | 19.36 | 861,730 | 5.25 | 34.27% |
| 5 Years | 6.91 | 29.86 | 5.35 | 18.84 | 692,898 | 13.66 | 197.68% |
Syndax Pharmaceuticals Description
| Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States. |
